ORKA Q2 2018 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$5,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-32.83

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10M

Total Liabilities

$1M

Stockholders' Equity

$9M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$5,000	-$7,000	+28.6%
Operating Income	-$2M	-$6M	+61.2%
Net Income	-$2M	-$6M	+61.7%